Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, October 14, 2014

Is It Time To Consider OncoMed Pharmaceuticals Again?

Given OncoMed's strong cash position and its partnerships, the company looks best positioned in the cancer stem cell therapy space. Every year an estimated 12 million people are diagnosed with cancer globally.

http://ift.tt/1r2GGMH
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts